Methylmalonic acidemia/propionic acidemia – the biochemical presentation and comparing the outcome between liver transplantation versus non-liver transplantation groups-Reference-Cited by-同舟云学术

Methylmalonic acidemia/propionic acidemia – the biochemical presentation and comparing the outcome between liver transplantation versus non-liver transplantation groups

Published:2019-04-02 Issue:1 Volume:14 Page:
ISSN:1750-1172
Container-title:Orphanet Journal of Rare Diseases
language:en
Short-container-title:Orphanet J Rare Dis

Author:

Chu Tzu-Hung,Chien Yin-Hsiu,Lin Hsiang-Yu,Liao Hsuan-Chieh,Ho Huey-Jane,Lai Chih-Jou,Chiang Chuan-Chi,Lin Niang-Cheng,Yang Chia-Feng,Hwu Wuh-Liang,Lee Ni-Chung,Lin Shuan-Pei,Liu Chin-Su,Hu Rey-Heng,Ho Ming-Chih,Niu Dau-Ming^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Genetics (clinical),General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13023-019-1045-1.pdf

Reference33 articles.

1. Lempp TJ, Suormala T, Siegenthaler R, Baumgartner ER, Fowler B, Steinmann B, et al. Mutation and biochemical analysis of 19 probands with mut0 and 13 with Mut- methylmalonic aciduria: identification of seven novel mutations. Mol Genet Metab [Internet]. 2007;90:284–90 Available from: http://www.sciencedirect.com/science/article/pii/S1096719206003234 .

2. Fraser JL, Venditti CP. Methylmalonic and propionic acidemias: clinical management update. CE Swati. 2016;28:682–93.

3. Kasahara M, Horikawa R, Tagawa M, Uemoto S, Yokoyama S, Shibata Y, et al. Current role of liver transplantation for methylmalonic acidemia: a review of the literature. Pediatr Transplant. 2006;10:943–7.

4. Kayler LK, Merion RM, Lee S, Sung RS, Punch JD, Rudich SM, et al. Long-term survival after liver transplantation in children with metabolic disorders. Pediatr Transplant [Internet]. 2002;6:295–300 Available from: http://www.ncbi.nlm.nih.gov/pubmed/12234269 .

5. Mazariegos G, Shneider B, Burton B, FoxI J, Hadzic N, Kishnani P, et al. Liver transplantation for pediatric metabolic disease. Mol Genet Metab. 2014;111:418–27 Available from: http://dx.doi.org/10.1016/j.ymgme.2014.01.006.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Further therapeutic applications of mRNA and saRNA;mRNA Therapeutics;2025

2. Clinical practice recommendations on kidney management in methylmalonic acidemia: an expert consensus statement from ERKNet and MetabERN;Kidney International Reports;2024-09

3. Long‐Term Outcomes of Living Donor Liver Transplantation for Methylmalonic Acidemia;Pediatric Transplantation;2024-08-05

4. An Early Cost-Utility Model of mRNA-Based Therapies for the Treatment of Methylmalonic and Propionic Acidemia in the United Kingdom;Clinical Drug Investigation;2024-05-25

5. Correlation between toxic organic acid fluctuations and neurodevelopment in patients with methylmalonic acidemia;2024-03-21